← Evidence map

ArticleExpert review of clinical pharmacology

Nirmatrelvir/Ritonavir and molnupiravir: an update on COVID-19 antivirals in the Omicron era.

Fatima Faraz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
pooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37800584